Report Categories
View AllRecent Articles
View All
GNPX Genprex reports narrower Q1 2025 loss than estimates shares drop 585 percent in todays trading
Syndax Pharmaceuticals SNDX Stock Price Movement Behavior Q4 2025 Earnings Underperform
Vanguard Real Estate ETF VNQ Office REIT Headwinds Drive Sector Pressure Amid Wall Street Downgrades
AMAL Amalgamated misses Q1 2026 EPS estimates by 174 percent shares fall 19 percent in todays trading